BioMarin Pharmaceutical (BMRN) Short Interest Ratio & Short Volume → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free BMRN Stock Alerts $80.91 -1.26 (-1.53%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability BioMarin Pharmaceutical Short Interest DataCurrent Short Volume3,690,000 sharesPrevious Short Volume3,060,000 sharesChange Vs. Previous Month+20.59%Dollar Volume Sold Short$337.67 millionShort Interest Ratio / Days to Cover2.6Last Record DateApril 15, 2024Outstanding Shares188,730,000 sharesPercentage of Shares Shorted1.96%Today's Trading Volume2,257,104 sharesAverage Trading Volume1,447,188 sharesToday's Volume Vs. Average156% Short Selling BioMarin Pharmaceutical ? Sign up to receive the latest short interest report for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBMRN Short Interest Over TimeBMRN Days to Cover Over TimeBMRN Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself BioMarin Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,690,000 shares $337.67 million +20.6%N/A2.6 $91.51 3/31/20243,060,000 shares $267.26 million +3.4%N/A2.3 $87.34 3/15/20242,960,000 shares $248.26 million -3.3%N/A2.2 $83.87 2/29/20243,060,000 shares $264.02 million -6.1%N/A2.1 $86.28 2/15/20243,260,000 shares $287.86 million +2.8%N/A2.2 $88.30 1/31/20243,170,000 shares $279.21 million -7.3%N/A1.9 $88.08 Get the Latest News and Ratings for BMRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,420,000 shares $319.19 million -7.6%N/A2 $93.33 12/31/20233,700,000 shares $356.75 million -15.5%N/A2.2 $96.42 12/15/20234,380,000 shares $425.56 million +29.6%N/A2.4 $97.16 11/30/20233,380,000 shares $307.85 million +9.7%N/A2 $91.08 11/15/20233,080,000 shares $268.14 million -6.4%N/A2 $87.06 10/31/20233,290,000 shares $267.97 million -53.2%N/A2.5 $81.45 10/15/20237,030,000 shares $606.97 million +7.5%N/A6.1 $86.34 9/30/20236,540,000 shares $578.66 million -0.5%N/A5.6 $88.48 9/15/20236,570,000 shares $579.21 million +5.1%N/A5.1 $88.16 8/31/20236,250,000 shares $571.13 million +3.1%N/A5 $91.38 8/15/20236,060,000 shares $549.46 million -2.4%N/A4.8 $90.67 7/31/20236,210,000 shares $546.05 million -6.3%N/A5 $87.93 7/15/20236,630,000 shares $569.32 million +51.4%N/A5.3 $85.87 6/30/20234,380,000 shares $379.66 million -27.0%N/A3.6 $86.68 6/15/20236,000,000 shares $575.04 million -10.9%N/A5.7 $95.84 5/31/20236,730,000 shares $585.11 million -3.9%N/A5.9 $86.94 5/15/20237,000,000 shares $666.26 million +4.2%N/A5.5 $95.18 4/30/20236,720,000 shares $645.39 million +4.5%N/A5.1 $96.04 4/15/20236,430,000 shares $636.63 million +8.3%3.5%4.7 $99.01 3/31/20235,940,000 shares $577.61 million -2.8%3.3%4.1 $97.24 3/15/20236,110,000 shares $536.09 million -16.1%3.4%4.1 $87.74 2/28/20237,280,000 shares $725.02 million +7.9%4.0%4.9 $99.59 2/15/20236,750,000 shares $730.22 million +3.2%3.7%4.6 $108.18 1/31/20236,540,000 shares $754.39 million -2.4%3.6%4.3 $115.35 1/15/20236,700,000 shares $755.22 million -35.3%3.7%4.3 $112.72 12/30/202210,360,000 shares $1.07 billion -1.7%5.7%6.7 $103.49 12/15/202210,540,000 shares $1.14 billion +3.2%5.8%7.2 $108.61 11/30/202210,210,000 shares $1.03 billion +4.0%5.6%7.4 $100.98 11/15/20229,820,000 shares $846.29 million -12.9%N/A7.7 $86.18 10/31/202211,270,000 shares $976.32 million -3.5%6.2%9.7 $86.63 10/15/202211,680,000 shares $1.02 billion +1.4%6.4%10.9 $87.25 9/30/202211,520,000 shares $976.55 million +0.3%6.3%11.6 $84.77 9/15/202211,490,000 shares $1.01 billion +0.6%6.3%11.5 $88.09 8/31/202211,420,000 shares $1.02 billion +0.7%6.3%10.5 $89.20Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. BMRN Short Interest - Frequently Asked Questions What is BioMarin Pharmaceutical's current short interest? Short interest is the volume of BioMarin Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,690,000 shares of BMRN short. Learn More on BioMarin Pharmaceutical's current short interest. What is a good short interest ratio for BioMarin Pharmaceutical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMRN shares currently have a short interest ratio of 3.0. Learn More on BioMarin Pharmaceutical's short interest ratio. Which institutional investors are shorting BioMarin Pharmaceutical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioMarin Pharmaceutical: DeepCurrents Investment Group LLC, Verition Fund Management LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioMarin Pharmaceutical's short interest increasing or decreasing? BioMarin Pharmaceutical saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,690,000 shares, an increase of 20.6% from the previous total of 3,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioMarin Pharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to BioMarin Pharmaceutical: Alnylam Pharmaceuticals, Inc. (1.98%), United Therapeutics Co. (9.96%), Ionis Pharmaceuticals, Inc. (7.12%), Madrigal Pharmaceuticals, Inc. (17.14%), Genmab A/S (0.40%), Teva Pharmaceutical Industries Limited (1.04%), Viatris Inc. (3.55%), BeiGene, Ltd. (1.92%), Karuna Therapeutics, Inc. (5.16%), Dr. Reddy's Laboratories Limited (0.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BioMarin Pharmaceutical stock? Short selling BMRN is an investing strategy that aims to generate trading profit from BioMarin Pharmaceutical as its price is falling. BMRN shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioMarin Pharmaceutical? A short squeeze for BioMarin Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BMRN, which in turn drives the price of the stock up even further. How often is BioMarin Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMRN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ALNY Short Interest UTHR Short Interest IONS Short Interest MDGL Short Interest GMAB Short Interest TEVA Short Interest VTRS Short Interest BGNE Short Interest KRTX Short Interest RDY Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BMRN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the Markets